(Q36030434)

11 August 2017

1 reference

title

Adipose tissue and atherothrombosis (English)

1 reference

11 August 2017

Marie-Christine Alessi

object named as

Marie-Christine Alessi

1

1 reference

ORCID Public Data File 2021

author name string

H Roger Lijnen

2

1 reference

PubMed ID

15692231

11 August 2017

Delphine Bastelica

3

1 reference

PubMed ID

15692231

11 August 2017

Irene Juhan-Vague

4

1 reference

11 August 2017

1 September 2003

1 reference

Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research

11 August 2017

1 reference

11 August 2017

33

1 reference

11 August 2017

290-297

1 reference

11 August 2017

5-6

1 reference

Leptin and the cardiovascular system

11 August 2017

1 reference

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

Adiponectin acts in the brain to decrease body weight.

21 January 2018

1 reference

Changes in the distribution pattern of gelatin-binding protein of 28 kDa (adiponectin) in myocardial remodelling after ischaemic injury

21 January 2018

1 reference

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL.

21 January 2018

1 reference

Globular adiponectin upregulates nitric oxide production in vascular endothelial cells

21 January 2018

1 reference

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells

21 January 2018

1 reference

Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin

21 January 2018

1 reference

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

21 January 2018

1 reference

Implications of plasma concentrations of adiponectin in patients with coronary artery disease

21 January 2018

1 reference

The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction

21 January 2018

1 reference

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease

21 January 2018

1 reference

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

21 January 2018

1 reference

C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

Monocyte chemoattractant protein 1 in obesity and insulin resistance

21 January 2018

1 reference

Tumour necrosis factor alpha: a key regulator of adipose tissue mass

21 January 2018

1 reference

Interleukin-6-deficient mice develop mature-onset obesity

21 January 2018

1 reference

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

What is the contribution of differences in three measures of tumor necrosis factor-alpha activity to insulin resistance in healthy volunteers?

21 January 2018

1 reference

Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level.

21 January 2018

1 reference

Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men.

21 January 2018

1 reference

Plasma tumor necrosis factor-alpha levels and insulin resistance in nondiabetic hypertensive subjects

21 January 2018

1 reference

Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease.

21 January 2018

1 reference

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

21 January 2018

1 reference

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

21 January 2018

1 reference

Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders.

21 January 2018

1 reference

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

21 January 2018

1 reference

Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study

21 January 2018

1 reference

The current biology of resistin

21 January 2018

1 reference

Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction

21 January 2018

1 reference

Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions

21 January 2018

1 reference

Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1.

21 January 2018

1 reference

Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice.

21 January 2018

1 reference

Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice

21 January 2018

1 reference

Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1

21 January 2018

1 reference

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

21 January 2018

1 reference

Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries

21 January 2018

1 reference

Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality

21 January 2018

1 reference

Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death

21 January 2018

1 reference

Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease

21 January 2018

1 reference

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

21 January 2018

1 reference

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.

21 January 2018

1 reference

Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.

21 January 2018

1 reference

Impaired fibrinolysis determines the outcome of percutaneus transluminal coronary angioplasty (PTCA).

21 January 2018

1 reference

Inflammation, thrombosis and atherosclerosis: results of the Glostrup study.

21 January 2018

1 reference

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

21 January 2018

1 reference

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

21 January 2018

1 reference

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.

21 January 2018

1 reference

Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1

21 January 2018

1 reference

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.

21 January 2018

1 reference

Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1.

21 January 2018

1 reference

Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

21 January 2018

Identifiers

0 references

1 reference

PubMed ID

15692231